(NASDAQ: STAA) Staar Surgical Co's forecast annual revenue growth rate of 10.58% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.06%.
Staar Surgical Co's revenue in 2026 is $290,375,000.On average, 13 Wall Street analysts forecast STAA's revenue for 2026 to be $16,542,227,464, with the lowest STAA revenue forecast at $13,587,280,286, and the highest STAA revenue forecast at $18,302,748,647. On average, 13 Wall Street analysts forecast STAA's revenue for 2027 to be $18,059,282,906, with the lowest STAA revenue forecast at $14,465,549,337, and the highest STAA revenue forecast at $20,315,199,615.
In 2028, STAA is forecast to generate $19,544,473,712 in revenue, with the lowest revenue forecast at $15,406,054,008 and the highest revenue forecast at $22,646,794,836.